To confirm if this mechanistic dependence on Bid holds consistent with ART-EMs and TRAIL combined, we used the trypan blue exclusion assay to assess cell death and the effect of Bid deficiency in cancer cell cytotoxicity. The gene discussed is BID; the disease is cancer.